Edition:
United States

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

4.47USD
18 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$4.47
Open
$4.54
Day's High
$4.56
Day's Low
$3.96
Volume
265,381
Avg. Vol
429,596
52-wk High
$10.38
52-wk Low
$1.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1.05 -0.502
Jun '18 0.84 -0.430
Mar '18 0.94 -0.320
FY 2017 Dec '17 1.62 -0.507
Sep '17 1.55 -0.556
Jun '17 1.15 -0.677
Mar '17 1.02 -0.603
FY 2016 Dec '16 4.06 -0.376
Sep '16 1.72 -0.537
Jun '16 1.45 -0.473
Mar '16 1.16 -0.870
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 1.12 1.40 1.00 1.62
Quarter Ending Mar-19 3 0.97 1.10 0.80 --
Year Ending Dec-18 4 3.95 4.24 3.80 2.46
Year Ending Dec-19 4 4.06 4.45 3.50 2.14
Earnings (per share)
Quarter Ending Dec-18 4 -0.43 -0.38 -0.51 -0.60
Quarter Ending Mar-19 3 -0.46 -0.38 -0.54 --
Year Ending Dec-18 4 -1.67 -1.62 -1.78 -2.45
Year Ending Dec-19 4 -1.79 -1.16 -2.35 -2.44
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.72 34.40
P/E High - Last 5 Yrs. -- 148.04 46.21
P/E Low - Last 5 Yrs. -- 47.80 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 6.98 49.54 6.22
Price to Book (MRQ) 1.08 10.17 5.20
Price to Tangible Book (MRQ) 1.08 13.82 6.74
Price to Cash Flow (TTM) -- 52.81 24.17
% Owned Institutions 74.37 3.75 1.77

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -20.95 129.94 8.17
Sales (TTM) vs TTM 1 Yr. Ago 57.47 47.86 6.50
Sales - 5 Yr. Growth Rate -- 22.77 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -43.17 75.89 23.27
EPS (TTM) vs TTM 1 Yr. Ago 2.39 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 5.65 3.43 3.10
LT Debt to Equity (MRQ) 0.00 18.73 11.49
Total Debt to Equity (MRQ) 0.00 31.43 16.03
Interest Coverage (TTM) -177.45 -43.28 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.35 54.44
Gross Margin - 5 Yr. Avg. -- 60.59 52.36
EBITD Margin (TTM) -660.33 -- --
EBITD - 5 Yr. Avg -- -109.93 13.16
Operating Margin (TTM) -664.11 -184.87 6.07
Operating Margin - 5 Yr. Avg. -- -126.36 8.47
Pre-Tax Margin (TTM) -657.71 -175.63 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.51 8.71
Net Profit Margin (TTM) -657.71 -182.37 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.91 4.90
Effective Tax Rate (TTM) -- 21.48 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.58 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) 111,873 7,652,294 873,073,486
Net Income/Employee (TTM) -735,803 652,908 103,486,338
Receivable Turnover (TTM) 18.26 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.15 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.82 6.46 11.45
Return on Assets - 5 Yr. Avg. -- 5.53 12.50
Return on Investment (TTM) -123.49 9.00 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -127.78 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.37
  1 Year 3 Year 5 Year
Sales % 94.43 94.41 --
EPS (TTM) % -68.75 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteostasis Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -3.45 39 98
13 Week -53.57 -55.83 3 94
26 Week -69.00 -71.36 4 98
52 Week -85.16 -87.42 3 68
YTD -81.97 -84.17 2 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.71%
# of Holders: 83
Total Shares Held: 27,879,887
3 Mo. Net Change: 3,918,723
# New Positions: 13
# Closed Positions: 14
# Increased Positions: 37
# Reduced Positions: 33
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.